#USA #New York #Securities Fraud #Pomerantz LLP #NeoGenomics

Pomerantz Law Firm Investigates NeoGenomics Investor Claims

Pomerantz LLP, a renowned law firm in the field of corporate and securities class litigation, is currently probing claims made on behalf of investors in NeoGenomics, Inc. (NASDAQ: NEO). The law firm has alerted investors following concerning financial disclosures from NeoGenomics, leading to a significant dip in stock prices. Any investors wanting more information can reach out directly to Danielle Peyton via email at [email protected] or call at 646-581-9980, ext. 7980.

Investigation Highlights

The investigation centers on allegations of potential securities fraud and other illegal business practices allegedly engaged in by NeoGenomics and some of its top executives. This inquiry is particularly timely following NeoGenomics' recent press release detailing its financial performance for the second quarter of 2025. The company revealed a disappointing revenue figure of $181.3 million, which fell far short of market expectations, coupled with a net loss of $45.1 million. In light of these results, NeoGenomics also adjusted its revenue forecasts downward for the full year from approximately $753 million to a new range of $720 million to $726 million.

Stock Market Reaction

On July 29, 2025, as the market reacted to these alarming disclosures, NeoGenomics' stock saw a steep decline, dropping by $1.21 per share, translating to an 18.73% decrease, leading to a closing price of $5.25. Such sharp declines often raise questions about the company's viability moving forward and whether there was a transparency issue regarding its financial health.

About Pomerantz LLP

Founded by the legendary Abraham L. Pomerantz, who is often referred to as the dean of the class action bar, Pomerantz LLP has spent over 85 years fighting for victims of securities fraud, corporate malfeasance, and breaches of fiduciary duty. The firm operates from several major cities including New York, Chicago, Los Angeles, London, Paris, and Tel Aviv. They have a storied history of recovering substantial damages for class members affected by unethical corporate behavior. More information can be found at www.pomlaw.com.

Conclusion

As NeoGenomics faces scrutiny in light of its disappointing financial results, Pomerantz LLP stands ready to pursue justice on behalf of its investors. The firm’s long-standing commitment to fighting corporate wrongdoing positions it as a pivotal player in safeguarding the rights of those affected. Investors are encouraged to seek legal guidance if they believe their interests may have been compromised by NeoGenomics' actions.